| Titolo |
Pubblicato in |
Anno |
| Rectal neuroendocrine tumors: Can we predict their behavior? |
WORLD JOURNAL OF GASTROENTEROLOGY |
2025 |
| Capecitabine and temozolomide or temozolomide alone in patients with atypical carcinoids |
ENDOCRINE |
2025 |
| Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database |
ENDOCRINE |
2024 |
| Endoscopic management of gastric, duodenal and rectal NETs: Position paper from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Society of Gastroenterology (SIGE), Italian Society of Digestive Endoscopy (SIED) |
DIGESTIVE AND LIVER DISEASE |
2024 |
| Type 3 gastric neuroendocrine neoplasms: the rising promise of conservative endoscopic management |
FRONTIERS IN MEDICINE |
2024 |
| Diagnostic and Therapeutic Management of Primary Orbital Neuroendocrine Tumors (NETs): Systematic Literature Review and Clinical Case Presentation |
BIOMEDICINES |
2024 |
| Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort |
JOURNAL OF CLINICAL MEDICINE |
2024 |
| Gastric neuroendocrine neoplasms |
NATURE REVIEWS. DISEASE PRIMERS |
2024 |
| Metastatic Type 1 low-grade gastric neuroendocrine tumor treated with peptide receptor radionuclide therapy in a young adult: a case report |
GASTROENTEROLOGY REPORT |
2024 |
| Clinical Outcome of Patients with Gastric, Duodenal, or Rectal Neuroendocrine Tumors after Incomplete Endoscopic Resection |
JOURNAL OF CLINICAL MEDICINE |
2024 |
| Gastrointestinal side effects of somatostatin analogs in neuroendocrine tumors: a focused review |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2024 |
| Convolutional neural network model for intestinal metaplasia recognition in gastric corpus using endoscopic image patches |
DIAGNOSTICS |
2024 |
| Comparative analysis of international guidelines on the management of advanced non-functioning well-differentiated pancreatic neuroendocrine tumors |
CANCER TREATMENT REVIEWS |
2024 |
| Sarcopenia in patients with advanced gastrointestinal well-differentiated neuroendocrine tumors |
NUTRIENTS |
2024 |
| Nutritional aspects in neuroendocrine neoplasms. bridging the gap between dietary interventions and cancer care strategies: a scoping review |
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION |
2024 |
| Radioligand therapy in the therapeutic strategy for patients with gastro-entero-pancreatic neuroendocrine tumors: a consensus statement from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Association of Nuclear Medicine (AIMN), Italian Society of Endocrinology (SIE), Italian Association of Medical Oncology (AIOM) |
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION |
2024 |
| Radiomics in advanced gastroenteropancreatic neuroendocrine neoplasms: Identifying responders to somatostatin analogs |
JOURNAL OF NEUROENDOCRINOLOGY |
2024 |
| Exploring carcinoid syndrome in neuroendocrine tumors: insights from a multidisciplinary narrative review |
CANCERS |
2024 |
| Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size. a retrospective, Europe-wide, pooled cohort study |
THE LANCET ONCOLOGY |
2023 |
| Targeting neuroendocrine tumors with octreotide and lanreotide: Key points for clinical practice from NET specialists |
CANCER TREATMENT REVIEWS |
2023 |
